The Bulletin
Men's Weekly


.

Poredeen Appoints ICB as Exclusive Named Patient Program Manager for HMTM# in Hong Kong and Macau

  • Written by The Bulletin

“Making TauRx’s groundbreaking drug HMTM# accessible to patients with Alzheimer's Disease under Named Patient Program”

HONG KONG SAR / SINGAPORE - Media OutReach Neswire - 18 January 2024 - ICB Medical Ltd ("ICB"), a member of the Immuno Cure BioTech Group ("Immuno Cure"), is appointed as the exclusive Named Patient Program ("NPP") Manager, for TauRx's groundbreaking drug, Hydromethylthionine Mesylate ("HMTM#"), in Hong Kong SAR and Macau SAR ("Territories") by Poredeen Pte Ltd ("Poredeen"), a wholly owned subsidiary within the TauRx Pharmaceuticals Ltd group of companies ("TauRx").

Read more: Poredeen Appoints ICB as Exclusive Named Patient Program Manager for HMTM# in Hong Kong and Macau

hacklink hack forum hacklink film izle hacklink สล็อตเว็บตรงbets10timebetbahisocasibomcasibomdeneme bonusucrown155aunorabahiscasibom한국야동casibom girişpadişahbetcasibomBetigma Girişgiftcardmall/mygift주소모음 주소모아spin2u casino loginneoaus96 casinoGalabetartemisbetmarsbahisjojobetgooglebets10ff96 appStreameaststakemate77best e-wallet pokies 2025jojobetpusulabetjojobet 1114matbet girişkavbetcasibomcasibom girişsadfasdfsdfasdasdasdasdkonya escortmatbetjojobetbetasus girişpin up azmamibetslotwww.giftcardmall.com/mygiftCasibomartemisbetbetasusbest e wallet pokies australiahttps://mrvip77.comsekabetbets10lunabetbets10casibomซื้อหวยออนไลน์casibom girişhazbetsitus slot gacorGalabetcasino non aams legalipusulabetsiti di scommessecasibom girişBest eSIM for Caribbean Cruisenuovi siti di scommessematbetjojobetartemisbetbetasusjojobetkonya escortmatbetjojobetpusulabetcasibomjojobet girişgiftcardmall/mygiftmamibet slotcasibom güncel girişholiganbet girişcasibom girişbets10Ganobetmarsbahiskonya escortholiganbetprimebahiscasibomsahabetmatbetbets10jojobetbetnanocasibomlimanbetbets10vdcasinojojobetMatbetjojobetmatbetonwin giriş